Brickell Biotech
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-13.40-3.28-0.00-0.01-0.01-0.01-0.02-0.00-0.02-0.01-0.20-0.01
Price/Sales ratio
17.5113.270.000.000.010.010.200.010.231.011.340.01
Price/Book Value ratio
3.441.660.000.000.000.000.000.010.010.010.390.00
Price/Cash Flow ratio
-17.46-3.43-0.00-0.01-0.01-0.02-0.02-0.00-0.02-0.01-0.21-0.02
Price/Free Cash Flow ratio
-16.47-3.35-0.00-0.01-0.01-0.02-0.02-0.00-0.02-0.01-0.21-0.02
Price/Earnings Growth ratio
0.080.090.000.000.00-0.000.00-0.000.000.00-0.13-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%-64.52%28.86%47.84%56.70%53.11%11.46%100%100%100%N/A53.11%
Operating Profit Margin
-133.75%-406.21%-109.25%-44.88%-63.15%-96.86%-1211.22%-309.05%-1151.26%-9753.71%-657.52%-96.86%
Pretax Profit Margin
-130.70%-404.74%-108.37%-44.09%-61.75%-93.78%-1002.09%-301.59%-1147.80%-9770.79%-643.48%-93.78%
Net Profit Margin
-130.70%-404.74%-108.37%-44.09%-61.75%-93.78%-1002.09%-301.59%-1147.80%-9787.87%-643.48%-93.78%
Effective Tax Rate
N/AN/A-0.81%-1.79%-2.27%-3.28%-27.57%-11.25%-0.30%-0.17%N/A-2.27%
Return on Assets
-23.72%-47.07%-28.44%-18.50%-17.16%-16.10%-31.05%-131.59%-62.17%-133.06%-161.43%-16.10%
Return On Equity
-25.70%-50.86%-31.76%-20.35%-19.87%-20.38%-33.33%-315.24%-77.07%-158.76%-156.09%-20.38%
Return on Capital Employed
-25.82%-50.00%-31.50%-20.55%-20.33%-21.05%-40.28%-319.96%-76.88%-158.20%-195.23%-21.05%
Liquidity Ratios
Current Ratio
14.8815.909.8610.696.694.5113.731.715.27N/A6.356.35
Quick Ratio
14.3515.049.8610.696.694.5114.051.715.276.155.225.22
Cash ratio
7.4610.633.933.230.701.463.310.684.745.585.040.70
Days of Sales Outstanding
44.83217.07N/AN/AN/AN/AN/AN/AN/AN/A40.09N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A-286.71N/AN/AN/AN/AN/A
Operating Cycle
N/A217.07N/AN/AN/AN/A-286.71N/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A11.357.6524.4818.9168.33104.72N/AN/AN/AN/A68.33
Cash Conversion Cycle
N/A205.71-7.65-24.48-18.91-68.33-391.43N/AN/AN/AN/A-18.91
Debt Ratios
Debt Ratio
0.070.07N/AN/AN/AN/A0.080.000.010.000.15N/A
Debt Equity Ratio
0.080.08N/AN/AN/AN/A0.090.010.010.000.18N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.000.00N/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.080.010.010.00N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-18.02-11.67N/AN/A-2.77KN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-3.11-238.28-39.20-523.88N/AN/A
Company Equity Multiplier
1.081.081.111.091.151.261.072.391.231.191.181.15
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.00-3.86-0.64-0.33-0.57-0.62-8.90-4.54-10.99-89.47-6.12-0.62
Free Cash Flow / Operating Cash Flow Ratio
1.061.021.031.011.031.001.001.001.001.0011.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-3.11-238.28-39.20-523.88N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-3.11-461.29-54.88-523.88-790.33N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A